Medium materiality6/10
Foghorn Therapeutics (FHTX) PT Lowered to $5 at H.C. Wainwright
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
FHTX PT lowered to $5; Current price $2.92; Analyst: Andrew Fein; Firm: H.C. Wainwright.
Target: $5
Posted price: $2.92
Analyst firm: H.C. Wainwright
Analyst: Andrew Fein
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.